We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.93B
AUM Growth
+$634M
Cap. Flow
+$193M
Cap. Flow %
3.91%
Top 10 Hldgs %
46.72%
Holding
190
New
7
Increased
53
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$17.4M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$13.1M
3
RUSHA icon
Rush Enterprises Class A
RUSHA
+$11.4M
4
CACC icon
Credit Acceptance
CACC
+$10.8M
5
OWL icon
Blue Owl Capital
OWL
+$10.2M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.79M
2
TCN
Tricon Residential Inc.
TCN
+$6.04M
3
SHW icon
Sherwin-Williams
SHW
+$3.09M
4
AAPL icon
Apple
AAPL
+$2.49M
5
JEF icon
Jefferies Financial Group
JEF
+$1.82M

Sector Composition

Rank Sector Weight
1 Financials 40.58%
2 Healthcare 13.65%
3 Technology 12.84%
4 Industrials 7.53%
5 Communication Services 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
151
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$247K 0.01%
473
– –
VLTO icon
152
Veralto
VLTO
$24.3B
$244K 0.01%
2,755
-666
-19% -$55.2K
FWONK icon
153
Liberty Media Series C
FWONK
$25.5B
$236K ﹤0.01%
+3,604
New +$242K
AMP icon
154
Ameriprise Financial
AMP
$47.8B
$236K ﹤0.01%
539
-93
-15% -$37.2K
MS icon
155
Morgan Stanley
MS
$319B
$235K ﹤0.01%
2,500
– –
MRSH
156
Marsh
MRSH
$94.3B
$231K ﹤0.01%
1,120
– –
QQQ icon
157
Invesco QQQ Trust
QQQ
$436B
$222K ﹤0.01%
500
– –
BB icon
158
BlackBerry
BB
$4.58B
$214K ﹤0.01%
77,650
-6,350
-8% -$18.6K
AMT icon
159
American Tower
AMT
$83.5B
$210K ﹤0.01%
1,063
– –
WBS icon
160
Webster Financial
WBS
$12.3B
$208K ﹤0.01%
4,091
– –
CET
161
Central Securities Corp
CET
$1.54B
$202K ﹤0.01%
+4,834
New +$187K
TMM
162
DELISTED
GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH
TMM
$183K ﹤0.01%
236,397
-400
-0.2% -$310
TCN
163
DELISTED
Tricon Residential Inc.
TCN
$178K ﹤0.01%
16,000
-566,941
-97% -$6.04M
VRCA icon
164
Verrica Pharmaceuticals
VRCA
$89M
$178K ﹤0.01%
3,000
– –
VTRS icon
165
Viatris
VTRS
$20.8B
$127K ﹤0.01%
10,667
– –
SJT
166
San Juan Basin Royalty Trust
SJT
$119M
$122K ﹤0.01%
22,980
– –
RIG icon
167
Transocean
RIG
$5.48B
$62.8K ﹤0.01%
10,000
– –
SENS icon
168
Senseonics Holdings Inc
SENS
$254M
$53.6K ﹤0.01%
+5,043
New +$58.5K
LUMN icon
169
Lumen
LUMN
$6.43B
$35.8K ﹤0.01%
22,923
-189,400
-89% -$296K
AMRN
170
Amarin Corp
AMRN
$297M
$26.7K ﹤0.01%
1,500
– –
AZN icon
171
AstraZeneca
AZN
$269B
– –
-1,732
Closed -$233K
BA icon
172
Boeing
BA
$169B
– –
-830
Closed -$216K
CL icon
173
Colgate-Palmolive
CL
$74.8B
– –
-4,576
Closed -$365K
OBDC icon
174
Blue Owl Capital
OBDC
$5.35B
– –
-34,000
Closed -$502K
VCMP
175
DELISTED
VCAMPUS CORP
VCMP
$0 ﹤0.01%
59,956
– –
3 4 5 6
7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q1 2024 Portfolio in Review

As of Q1 2024, Beck Mack & Oliver held 190 positions worth $4.93B, up 15% from $4.3B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver deployed $193M of net new capital in Q1 2024, opening 7 new positions and adding to 53 existing holdings. Its largest new stake was Smith Douglas Homes: 142,029 shares worth $4.22M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $6.79M trimmed.

  • Beck Mack & Oliver's largest Q1 2024 buy was Smith Douglas Homes: 142,029 shares worth $4.22M.
  • Beck Mack & Oliver added most to Amazon in Q1 2024, an estimated $17.4M increase.
  • Beck Mack & Oliver's biggest Q1 2024 reduction was Teva Pharmaceuticals, cutting an estimated $6.79M.
  • Beck Mack & Oliver fully exited Blue Owl Capital in Q1 2024, selling an estimated $502K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $4.93B portfolio in Q1 2024.
  • Beck Mack & Oliver opened 7 new positions and closed 11 in Q1 2024.
  • Beck Mack & Oliver's portfolio value rose 15% quarter-over-quarter to $4.93B.

Based on Beck Mack & Oliver's 13F filing for Q1 2024, filed 14 May 2024.